Pharmaceutical giant Eli Lilly (LLY) lost approximately $120 billion in market value this week following an announcement from competitor Viking Therapeutics (VKTX). The biotech company revealed promising progress toward developing its own weight-loss drug, potentially challenging Eli Lilly's dominance in this market.

Yahoo Finance senior health reporter Anjalee Khemlani breaks down the details.

For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.

This post was written by Angel Smith